private health insurance

Spiral

Behind the private health insurance ‘death spiral’

By Sarah Griffin | 26 August, 2019
The Grattan Institute report ‘The history and purposes of private insurance’ [1] by Stephen Duckett and Kristina Nemet made headlines in Australia last month, particularly the somewhat lurid language describing...
PrivateXhealthXinsurance

Ongoing Reform of Private Health Insurance – what it means for Medical Devices

By Sarah Griffin | 1 November, 2018
Private Health Insurance (PHI) in Australia has been under the microscope for several years. With nearly half of all Australians choosing to purchase PHI, and a level of government subsidy...

Search

Recent Posts

New Guidance on FDA ISO 10993-1

Sep 14, 2020

Australian Prescription Medicine Pathways – Project Orbis

Sep 1, 2020

TGA Advertisement Framework Revisions Hard at Work During Pandemic Times

Aug 31, 2020

Chemical Characterisation – no simple matter

Aug 28, 2020

Multiple Function Devices

Aug 26, 2020

Impact of COVID-19 on Medical Device Sales and Reimbursement in Australia

Aug 10, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) APAC Australia Biocompatibility Brexit CE CE Certificates clinical trials coronavirus COVID-19 COVID19 de novo distribution Drug EU Europe FDA guidance ISO 10993-18 IVD IVDD IVDR MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines New Zealand Notified Bodies Pharmaceutical PMA PMDA postmarket private health insurance Quality Systems Reform regulatory Reimbursement SaMD Software standards TGA